Darolutamide Tablets.Daroltamide tablets are a Western medicine. They are clinically used to treat adult patients with non-metastatic castration-resistant prostate cancer (NM-CRPC) who have a high risk of metastasis.
The main ingredient of Daroltamide tablets is daroltamide, an androgen receptor (AR) inhibitor that competitively inhibits the binding of androgens to AR, thereby inhibiting AR nuclear translocation and AR-mediated transcription.